Behind the Science: Behind Advances in CAR-T Therapy

At the 64th American Society of Hematology Annual Meeting, the CGTLive team caught up with experts in the clinical care of patients who are receiving cell and gene treatments. A variety of data were presented on the latest advances in CAR-T therapies that are being evaluated for different patient populations. Specifically, they offered insight into the trends they’ve observed in the development of these treatments, the needs that are lingering where progress has been made, and much more.